P I Industries Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,376Cr
- −27.6% YoY
- −26.5% QoQ
- Net profit
- ₹311Cr
- −16.6% YoY
- −24% QoQ
- Margin
- 22%
- −5 pp YoY
- −7 pp QoQ
Guidance rank: #17 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
P I Industries Ltd Q3 FY26 key numbers
- Revenue
- Growth in the contract research and manufacturing (CRDMO) pharma business expected to strengthen as capabilities mature, targeting EBITDA positivity once topline hits INR 400-500 crore.
As stated in P I Industries Ltd's Q3 FY26 earnings call transcript · published 3 Aug 2026. Reported figures, not investment advice.
The short version
Sequential volume growth expected beginning Q4 FY26, with recovery momentum building into FY27. Q4 FY26 expected to show sequential volume growth, with initial signs of recovery beginning.
From P I Industries Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Sequential volume growth expected beginning Q4 FY26, with recovery momentum building into FY27.
- FY27 is anticipated to see overall revenue growth as industry conditions stabilize and new product ramp-up progresses.
- Growth in the contract research and manufacturing (CRDMO) pharma business expected to strengthen as capabilities mature, targeting EBITDA positivity once topline hits INR 400-500 crore.
- Domestic agrochemical growth projected to return on track from FY27 following subdued demand in FY26 due to high channel inventory and regulatory impacts.
2 more points from P I Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what P I Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY27 capex guidance is broadly INR 500 crore to INR 600 crore, with formal guidance expected post Board approval next quarter.
- Plans are underway for setting up a pharma intermediate plant in India; further details to be announced soon.
- Expansion from 2 to 3 multipurpose plants, with the third plant largely targeted for pharma business.
- Company is actively evaluating various strategic and synergistic investment opportunities aligned with knowledge-led capabilities, both within AgChem and potentially outside it.
2 more points from P I Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what P I Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- As of the quarter ending December 31, 2025, the order book stands at approximately $1.2 billion.
- The company regularly shares updates on the order book and this figure was confirmed during the earnings call.
- Relationships with large European and American customers continue to add new products and evaluations.
2 more points from P I Industries Ltd's call on order book
Create a free account to keep reading this call
P I Industries Ltd — Quarterly revenue & net profit
P I Industries Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,376 | 1,901 | -27.6% | 1,872 | -26.5% |
| Operating profit (EBITDA) | 302 | 512 | -41% | 541 | -44.2% |
| Operating margin | 22% | 27% | -5 pp | 29% | -7 pp |
| Profit before tax | 363 | 481 | -24.5% | 525 | -30.9% |
| Net profit (PAT) | 311 | 373 | -16.6% | 409 | -24% |
| EPS (₹) | 20.52 | 24.57 | -16.5% | 26.98 | -23.9% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.7K Cr, net profit ₹122 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What P I Industries's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Bhagiradha Chemicals & Industries (Q3 FY26)
114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran
- Advance Agrolife (Q3 FY26)
Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways
- Khaitan Chemical (Q3 FY26)
Q3-FY26 operational revenue: INR 2,657 million, up 34% year-on-year (Page 23, 24). Key investor presentation takeaways from Khaitan Chemical's Q3 FY26 investor
- Rama Phosphates (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹23,800 lakhs, up 33% YoY (Q3 FY25: ₹17,962 lakhs) [Page 9] . Key investor presentation takeaways from Rama Phosphates's Q3 FY2
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- Madhya Bharat Agro ProductsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
P I Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were P I Industries Ltd Q3 FY26 results?
Sequential volume growth expected beginning Q4 FY26, with recovery momentum building into FY27. Q4 FY26 expected to show sequential volume growth, with initial signs of recovery beginning.
What is P I Industries Ltd share price analysis?
P I Industries Ltd currently shows a neutral. The stock trades at a P/E of 35.5 with a market cap of ₹42,633 Cr. Investors should review the full earnings analysis for detailed insights.
Is P I Industries Ltd planning capital expenditure?
FY27 capex guidance is broadly INR 500 crore to INR 600 crore, with formal guidance expected post Board approval next quarter.
Keep P I Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
